Suchergebnisse
Seiko Epson Corp.
WKN: 471496 / Name: Seiko Epson / Aktie / Büroausstattung / Small Cap /
Epsilon Healthcare Ltd.
WKN: A2QQBW / Name: Epsilon Healthcare / Aktie / Micro Cap /
Can Altria Sustain EPS Growth Momentum Through 2026?
As Altria Group, Inc. MO moves further into 2026, the sustainability of its earnings per share (EPS) growth is drawing close attention. The company expects adjusted EPS of $5.56 to $5.72
Is WisdomTree U.S. LargeCap ETF (EPS) a Strong ETF Right Now?
Designed to provide broad exposure to the Style Box - Large Cap Value category of the market, the WisdomTree U.S. LargeCap ETF (EPS) is a smart beta exchange traded fund launched on 02/23/2007.
Cirrus Logic Q3 Earnings & Revenues Surpass Estimates, Rise Y/Y
Cirrus Logic, Inc. CRUS reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.97, which surpassed the Zacks Consensus Estimate of $2.42. The company reported adjusted EPS of
CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains
Cardinal Health, Inc. CAH reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.63, which beat the Zacks Consensus Estimate of $2.39 by 10%. The bottom line also improved 36.3%
PepsiCo's Productivity Strategy: A Catalyst for EPS Expansion?
PepsiCo, Inc.’s PEP productivity strategy is a key lever for earnings per share (EPS) expansion, particularly in a challenging operating environment. The company is driving productivity through a
Molina Healthcare Incurs a Loss in Q4 as Medical Costs Surge
Molina Healthcare, Inc. MOH reported a fourth-quarter 2025 adjusted loss of $2.75 per share, which missed the Zacks Consensus Estimate of an adjusted EPS of 43 cents. The company reported an EPS of
BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View
Biogen BIIB reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.99, which beat the Zacks Consensus Estimate of $1.61. Earnings declined 42% year over year.
Total revenues during the
ECL Stock Falls in Pre-Market Despite Q4 Earnings Beat, Margins Expand
Ecolab Inc. ECL has reported fourth-quarter 2025 adjusted earnings per share (EPS) of $2.08, up 14.9% year over year. The bottom line surpassed the Zacks Consensus Estimate by 0.8%.
GAAP EPS for the
Generac Misses Q4 Earnings & Sales Estimates, Provides 2026 Outlook
Generac Holdings Inc. GNRC has reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.61, which missed the Zacks Consensus Estimate of $1.81. GNRC had registered an adjusted EPS of
Zillow Group's Q4 EPS Lags Estimates, Revenues Beat Y/Y
Zillow Group Z reported its fourth-quarter 2025 adjusted earnings per share (EPS) of 39 cents, which missed the Zacks Consensus Estimate of 42 cents. The figure increased significantly on a
Can Willdan's Deal Pipeline Power 2026 EPS Growth Ahead?
Willdan Group WLDN is closing 2025 with strong momentum, and the key investor question is whether its expanding deal pipeline can translate into another year of solid EPS growth in
Krystal Biotech Q4 Earnings Beat Estimates, Revenues Miss Mark
Krystal Biotech KRYS reported fourth-quarter 2025 earnings per share (EPS) of $1.70, which surpassed the Zacks Consensus Estimate of $1.62. The reported EPS was up from $1.52 in the year-ago
How to Boost Your Portfolio with Top Consumer Discretionary Stocks Set to Beat Earnings
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
These 2 Oils and Energy Stocks Could Beat Earnings: Why They Should Be on Your Radar
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
PTC to Report Q1 Earnings: Here's What Investors Should Expect
PTC Inc. PTC is scheduled to report first-quarter fiscal 2026 results on Feb. 4, after market close.For the quarter, PTC anticipates revenues between $600 million and $660 million. Non-GAAP EPS is
Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates
Revvity, Inc. RVTY reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.70, which beat the Zacks Consensus Estimate of $1.63 by 4.3%. The bottom line improved 19.7% from the year-ago
Gentex Q4 Earnings Match Estimates, Revenues Increase Y/Y
Gentex Corporation’s GNTX fourth-quarter 2025 adjusted earnings per share (EPS) of 43 cents matched the Zacks Consensus Estimate and increased from 39 cents reported a year ago.
This Zeeland-based


